Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

History of tuberculosis is associated with lower exhaled nitric oxide levels in HIV-infected children.

Sovershaeva E, Kranzer K, Mchugh G, Bandason T, Majonga ED, Usmani OS, Rowland-Jones S, Gutteberg T, Flægstad T, Ferrand RA, Odland JØ.

AIDS. 2019 May 11. doi: 10.1097/QAD.0000000000002265. [Epub ahead of print]

PMID:
31107249
2.

Multicentre study to establish interpretive criteria for clofazimine drug susceptibility testing.

Ismail NA, Said HM, Rodrigues C, Omar SV, Ajbani K, Sukhadiad N, Kohl TA, Niemann S, Kranzer K, Diels M, Rigouts L, Rüsch-Gerdes S, Siddiqi S.

Int J Tuberc Lung Dis. 2019 May 1;23(5):594-599. doi: 10.5588/ijtld.18.0417.

PMID:
31097068
3.

New WHO Treatment Recommendations for Multidrug-Resistant Tuberculosis: Are We Well Enough Prepared?

Kranzer K, Kalsdorf B, Heyckendorf J, Andres S, Merker M, Hofmann-Thiel S, Bloemberg GV, Hoffmann H, Niemann S, Lange C, Maurer FP.

Am J Respir Crit Care Med. 2019 Apr 26. doi: 10.1164/rccm.201902-0260LE. [Epub ahead of print] No abstract available.

PMID:
31026398
4.

Emergence of Low-level Delamanid and Bedaquiline Resistance During Extremely Drug-resistant Tuberculosis Treatment.

Polsfuss S, Hofmann-Thiel S, Merker M, Krieger D, Niemann S, Rüssmann H, Schönfeld N, Hoffmann H, Kranzer K.

Clin Infect Dis. 2019 Feb 2. pii: ciz074. doi: 10.1093/cid/ciz074. [Epub ahead of print]

PMID:
30933266
5.

Random glucose sampling as screening tool for diabetes among disadvantaged tuberculosis patients residing in urban slums in India.

Gröschel MI, Luz CF, Batra S, Ahuja S, Batra S, Kranzer K, van der Werf TS.

ERJ Open Res. 2019 Mar 11;5(1). pii: 00025-2019. doi: 10.1183/23120541.00025-2019. eCollection 2019 Feb.

6.

'Those who cannot remember the past are condemned to repeat it': Drug-susceptibility testing for bedaquiline and delamanid.

Köser CU, Maurer FP, Kranzer K.

Int J Infect Dis. 2019 Mar;80S:S32-S35. doi: 10.1016/j.ijid.2019.02.027. Epub 2019 Feb 25.

7.

World Tuberculosis Day March 24th 2019 Theme: "It's TIME" - International Journal of Infectious Diseases Tuberculosis Theme Series.

Petersen E, Rao M, Ippolito G, Gualano G, Chakaya J, Ntoumi F, Moore D, Allen R, Gaskell K, Öhd JN, Hergens MP, Krishnamoorthy S, Ugarte-Gil C, Kirwan DE, Honeyborne I, McHugh TD, Köser CU, Kranzer K, Tiberi S, Migliori GB, Mao Q, Yang Y, Oliveira SP, Cardoso RF, Detjen A, Marais B, de Gijsel D, von Reyn CF, Goscé L, Abubakar I, Maeurer M, Zumla A.

Int J Infect Dis. 2019 Mar;80S:S1-S5. doi: 10.1016/j.ijid.2019.02.024. Epub 2019 Feb 23. No abstract available.

8.

Novel external quality assurance scheme for drug susceptibility testing of non-tuberculous mycobacteria: a multicentre pilot study.

Nikolayevskyy V, Maurer FP, Holicka Y, Taylor L, Liddy H, Kranzer K.

J Antimicrob Chemother. 2019 Feb 11. doi: 10.1093/jac/dkz027. [Epub ahead of print]

PMID:
30753511
9.

Validation of the FluoroType® MTBDR assay using respiratory and lymph node samples.

Haasis C, Rupp J, Andres S, Schlüter B, Kernbach M, Hillemann D, Kranzer K.

Tuberculosis (Edinb). 2018 Dec;113:76-80. doi: 10.1016/j.tube.2018.09.004. Epub 2018 Sep 19.

PMID:
30514516
10.

A Diagnostic Algorithm To Investigate Pyrazinamide and Ethambutol Resistance in Rifampin-Resistant Mycobacterium tuberculosis Isolates in a Low-Incidence Setting.

Andres S, Gröschel MI, Hillemann D, Merker M, Niemann S, Kranzer K.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01798-18. doi: 10.1128/AAC.01798-18. Print 2019 Feb.

11.

Screening tool to identify adolescents living with HIV in a community setting in Zimbabwe: A validation study.

Bandason T, Dauya E, Dakshina S, McHugh G, Chonzi P, Munyati S, Weiss HA, Simms V, Kranzer K, Ferrand RA.

PLoS One. 2018 Oct 2;13(10):e0204891. doi: 10.1371/journal.pone.0204891. eCollection 2018.

12.

Computer-assisted chest radiography reading for tuberculosis screening in people living with diabetes mellitus.

Koesoemadinata RC, Kranzer K, Livia R, Susilawati N, Annisa J, Soetedjo NNM, Ruslami R, Philipsen R, van Ginneken B, Soetikno RD, van Crevel R, Alisjahbana B, Hill PC.

Int J Tuberc Lung Dis. 2018 Sep 1;22(9):1088-1094. doi: 10.5588/ijtld.17.0827.

PMID:
30092877
13.

Smear Microscopy for Diagnosis of Pulmonary Tuberculosis in Eastern Sudan.

Shuaib YA, Khalil EAG, Schaible UE, Wieler LH, Bakheit MAM, Mohamed-Noor SE, Abdalla MA, Homolka S, Andres S, Hillemann D, Lonnroth K, Richter E, Niemann S, Kranzer K.

Tuberc Res Treat. 2018 Jun 14;2018:8038137. doi: 10.1155/2018/8038137. eCollection 2018.

14.

Evaluation of OMNIgene®•SPUTUM reagent for mycobacterial culture.

Zallet J, Olaru ID, Witt AK, Vock P, Kalsdorf B, Andres S, Hillemann D, Kranzer K.

Int J Tuberc Lung Dis. 2018 Aug 1;22(8):945-949. doi: 10.5588/ijtld.17.0020.

15.

What if They Don't Have Tuberculosis? The Consequences and Trade-offs Involved in False-positive Diagnoses of Tuberculosis.

Houben RMGJ, Lalli M, Kranzer K, Menzies NA, Schumacher SG, Dowdy DW.

Clin Infect Dis. 2019 Jan 1;68(1):150-156. doi: 10.1093/cid/ciy544.

16.

Differential drug susceptibility patterns of Mycobacterium chimaera and other members of the Mycobacterium avium-intracellulare complex.

Maurer FP, Pohle P, Kernbach M, Sievert D, Hillemann D, Rupp J, Hombach M, Kranzer K.

Clin Microbiol Infect. 2019 Mar;25(3):379.e1-379.e7. doi: 10.1016/j.cmi.2018.06.010. Epub 2018 Jun 12.

PMID:
29906595
17.

Disseminierte kutane Infektion mit Mycobacterium marinum bei chronischem Lymphödem bei einem immunkompetenten Patienten.

Schliemann S, Räßler F, Tittelbach J, Kranzer K, Zollmann C, Elsner P.

J Dtsch Dermatol Ges. 2018 May;16(5):613-616. doi: 10.1111/ddg.13491_g. No abstract available.

PMID:
29750466
18.

Racial Variation in Echocardiographic Reference Ranges for Left Chamber Dimensions in Children and Adolescents: A Systematic Review.

Majonga ED, Norrish G, Rehman AM, Kranzer K, Mujuru HA, Nathoo K, Odland JO, Kaski JP, Ferrand RA.

Pediatr Cardiol. 2018 Jun;39(5):859-868. doi: 10.1007/s00246-018-1873-0. Epub 2018 Apr 4. Review.

19.

Disseminated Mycobacterium marinum skin infection due to chronic lymphedema in an immunocompetent patient.

Schliemann S, Rässler F, Tittelbach J, Kranzer K, Zollmann C, Elsner P.

J Dtsch Dermatol Ges. 2018 May;16(5):614-616. doi: 10.1111/ddg.13491. Epub 2018 Mar 30. No abstract available.

PMID:
29603601
20.

Validation of the FluoroType MTBDR Assay for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates.

Hillemann D, Haasis C, Andres S, Behn T, Kranzer K.

J Clin Microbiol. 2018 May 25;56(6). pii: e00072-18. doi: 10.1128/JCM.00072-18. Print 2018 Jun.

21.

Impact of quality improvement in tuberculosis laboratories in low- and lower-middle-income countries: a systematic review.

Olaru ID, Albert H, Zallet J, Werner UE, Ahmed N, Rieder HL, Salfinger M, Kranzer K.

Int J Tuberc Lung Dis. 2018 Mar 1;22(3):309-320. doi: 10.5588/ijtld.17.0629.

PMID:
29471910
22.

A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study.

Walker TM, Merker M, Knoblauch AM, Helbling P, Schoch OD, van der Werf MJ, Kranzer K, Fiebig L, Kröger S, Haas W, Hoffmann H, Indra A, Egli A, Cirillo DM, Robert J, Rogers TR, Groenheit R, Mengshoel AT, Mathys V, Haanperä M, Soolingen DV, Niemann S, Böttger EC, Keller PM; MDR-TB Cluster Consortium.

Lancet Infect Dis. 2018 Apr;18(4):431-440. doi: 10.1016/S1473-3099(18)30004-5. Epub 2018 Jan 8. Erratum in: Lancet Infect Dis. 2018 Jan 10;:.

23.

Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial.

Gonzalez-Martinez C, Kranzer K, McHugh G, Corbett EL, Mujuru H, Nicol MP, Rowland-Jones S, Rehman AM, Gutteberg TJ, Flaegstad T, Odland JO, Ferrand RA; BREATHE study team.

Trials. 2017 Dec 28;18(1):622. doi: 10.1186/s13063-017-2344-2.

24.

The case for viral load testing in adolescents in resource-limited settings.

Marcus R, Ferrand RA, Kranzer K, Bekker LG.

J Int AIDS Soc. 2017 Nov;20 Suppl 7. doi: 10.1002/jia2.25002. Review.

25.

Economic incentives for HIV testing by adolescents in Zimbabwe: a randomised controlled trial.

Kranzer K, Simms V, Bandason T, Dauya E, McHugh G, Munyati S, Chonzi P, Dakshina S, Mujuru H, Weiss HA, Ferrand RA.

Lancet HIV. 2018 Feb;5(2):e79-e86. doi: 10.1016/S2352-3018(17)30176-5. Epub 2017 Nov 20.

26.

Disability, social functioning and school inclusion among older children and adolescents living with HIV in Zimbabwe.

Rukuni R, McHugh G, Majonga E, Kranzer K, Mujuru H, Munyati S, Nathoo K, Gregson CL, Kuper H, Ferrand RA.

Trop Med Int Health. 2018 Feb;23(2):149-155. doi: 10.1111/tmi.13012. Epub 2017 Dec 26.

27.

The effect of community-based support for caregivers on the risk of virological failure in children and adolescents with HIV in Harare, Zimbabwe (ZENITH): an open-label, randomised controlled trial.

Ferrand RA, Simms V, Dauya E, Bandason T, Mchugh G, Mujuru H, Chonzi P, Busza J, Kranzer K, Munyati S, Weiss HA, Hayes RJ.

Lancet Child Adolesc Health. 2017 Nov;1(3):175-183. doi: 10.1016/S2352-4642(17)30051-2.

28.

Mycobacterium tuberculosis transmission from patients with drug-resistant compared to drug-susceptible TB: a systematic review and meta-analysis.

Kodama C, Lange B, Olaru ID, Khan P, Lipman M, Seddon JA, Sloan D, Grandjean L, Ferrand RA, Kranzer K.

Eur Respir J. 2017 Oct 26;50(4). pii: 1701044. doi: 10.1183/13993003.01044-2017. Print 2017 Oct. No abstract available.

29.

Does antiretroviral treatment increase the infectiousness of smear-positive pulmonary tuberculosis?

Khan PY, Crampin AC, Mzembe T, Koole O, Fielding KL, Kranzer K, Glynn JR.

Int J Tuberc Lung Dis. 2017 Nov 1;21(11):1147-1154. doi: 10.5588/ijtld.17.0162.

30.

Turnaround time of whole genome sequencing for mycobacterial identification and drug susceptibility testing in routine practice.

Olaru ID, Patel H, Kranzer K, Perera N.

Clin Microbiol Infect. 2018 Jun;24(6):659.e5-659.e7. doi: 10.1016/j.cmi.2017.10.001. Epub 2017 Oct 10.

31.

Human Immunodeficiency Virus-Associated Chronic Lung Disease in Children and Adolescents in Zimbabwe: Chest Radiographic and High-Resolution Computed Tomographic Findings.

Desai SR, Nair A, Rylance J, Mujuru H, Nathoo K, McHugh G, Majonga E, Metcalfe J, Kranzer K, Ferrand RA.

Clin Infect Dis. 2018 Jan 6;66(2):274-281. doi: 10.1093/cid/cix778.

32.

[Consensus-Based Guidelines for Diagnosis, Prevention and Treatment of Tuberculosis in Children and Adolescents - A Guideline on Behalf of the German Society for Pediatric Infectious Diseases (DGPI)].

Feiterna-Sperling C, Brinkmann F, Adamczick C, Ahrens F, Barker M, Berger C, Berthold LD, Bogyi M, von Both U, Frischer T, Haas W, Hartmann P, Hillemann D, Hirsch FW, Kranzer K, Kunitz F, Maritz E, Pizzulli A, Ritz N, Schlags R, Spindler T, Thee S, Weizsäcker K.

Pneumologie. 2017 Oct;71(10):629-680. doi: 10.1055/s-0043-116545. Epub 2017 Oct 10. German.

PMID:
29017219
33.

False-negative HIV tests using oral fluid tests in children taking antiretroviral therapy from Harare, Zimbabwe.

Olaru ID, McHugh G, Dakshina S, Majonga E, Dauya E, Bandason T, Kranzer K, Mujuru H, Ferrand RA.

J Int AIDS Soc. 2017 Aug 29;20(Suppl 6):21751. doi: 10.7448/IAS.20.7.21751.

34.

Clinical outcomes in children and adolescents initiating antiretroviral therapy in decentralized healthcare settings in Zimbabwe.

McHugh G, Simms V, Dauya E, Bandason T, Chonzi P, Metaxa D, Munyati S, Nathoo K, Mujuru H, Kranzer K, Ferrand RA.

J Int AIDS Soc. 2017 Sep 1;20(1):21843. doi: 10.7448/IAS.20.1.21843.

35.

Community burden of undiagnosed HIV infection among adolescents in Zimbabwe following primary healthcare-based provider-initiated HIV testing and counselling: A cross-sectional survey.

Simms V, Dauya E, Dakshina S, Bandason T, McHugh G, Munyati S, Chonzi P, Kranzer K, Ncube G, Masimirembwa C, Thelingwani R, Apollo T, Hayes R, Weiss HA, Ferrand RA.

PLoS Med. 2017 Jul 25;14(7):e1002360. doi: 10.1371/journal.pmed.1002360. eCollection 2017 Jul.

36.

Loss to follow-up among children and adolescents growing up with HIV infection: age really matters.

Kranzer K, Bradley J, Musaazi J, Nyathi M, Gunguwo H, Ndebele W, Dixon M, Ndhlovu M, Rehman A, Khan P, Vogt F, Apollo T, Ferrand RA.

J Int AIDS Soc. 2017 Jul 17;20(1):21737. doi: 10.7448/IAS.20.1.21737.

37.

Global outbreak of severe Mycobacterium chimaera disease after cardiac surgery: a molecular epidemiological study.

van Ingen J, Kohl TA, Kranzer K, Hasse B, Keller PM, Katarzyna Szafrańska A, Hillemann D, Chand M, Schreiber PW, Sommerstein R, Berger C, Genoni M, Rüegg C, Troillet N, Widmer AF, Becker SL, Herrmann M, Eckmanns T, Haller S, Höller C, Debast SB, Wolfhagen MJ, Hopman J, Kluytmans J, Langelaar M, Notermans DW, Ten Oever J, van den Barselaar P, Vonk ABA, Vos MC, Ahmed N, Brown T, Crook D, Lamagni T, Phin N, Smith EG, Zambon M, Serr A, Götting T, Ebner W, Thürmer A, Utpatel C, Spröer C, Bunk B, Nübel U, Bloemberg GV, Böttger EC, Niemann S, Wagner D, Sax H.

Lancet Infect Dis. 2017 Oct;17(10):1033-1041. doi: 10.1016/S1473-3099(17)30324-9. Epub 2017 Jul 12.

PMID:
28711585
38.

Echocardiographic reference ranges in older children and adolescents in sub-Saharan Africa.

Majonga ED, Rehman AM, McHugh G, Mujuru HA, Nathoo K, Patel MS, Munyati S, Odland JO, Kranzer K, Kaski JP, Ferrand RA.

Int J Cardiol. 2017 Dec 1;248:409-413. doi: 10.1016/j.ijcard.2017.06.109. Epub 2017 Jun 30.

39.

How should discordance between molecular and growth-based assays for rifampicin resistance be investigated?

Hofmann-Thiel S, Hoffmann H, Hillemann D, Rigouts L, Van Deun A, Kranzer K.

Int J Tuberc Lung Dis. 2017 Jul 1;21(7):721-726. doi: 10.5588/ijtld.17.0140.

PMID:
28633695
40.

Radiological screening of refugees in Germany.

Herzmann C, Golakov M, Malekzada F, Lonnroth K, Kranzer K.

Eur Respir J. 2017 May 25;49(5). pii: 1602487. doi: 10.1183/13993003.02487-2016. Print 2017 May. No abstract available.

41.

Challenges in the Estimation of the Annual Risk of Mycobacterium tuberculosis Infection in Children Aged Less Than 5 Years.

Khan PY, Glynn JR, Mzembe T, Mulawa D, Chiumya R, Crampin AC, Kranzer K, Fielding KL.

Am J Epidemiol. 2017 Oct 15;186(8):1015-1022. doi: 10.1093/aje/kwx153.

42.

Carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in HIV-infected children in Zimbabwe.

Wilmore SMS, Kranzer K, Williams A, Makamure B, Nhidza AF, Mayini J, Bandason T, Metcalfe J, Nicol MP, Balakrishnan I, Ellington MJ, Woodford N, Hopkins S, McHugh TD, Ferrand RA.

J Med Microbiol. 2017 May;66(5):609-615. doi: 10.1099/jmm.0.000474. Epub 2017 May 18.

43.

Language discordance between tuberculosis patients and healthcare providers challenging universal access.

Nakiwala D, Kellgren L, Herzmann C, Olaru ID, Brown M, Ferrand R, Khan P, Kranzer K.

Eur Respir J. 2017 Apr 19;49(4). pii: 1700116. doi: 10.1183/13993003.00116-2017. Print 2017 Apr. No abstract available.

44.

Diagnostic accuracy of the Xpert® MTB/RIF cycle threshold level to predict smear positivity: a meta-analysis.

Lange B, Khan P, Kalmambetova G, Al-Darraji HA, Alland D, Antonenka U, Brown T, Balcells ME, Blakemore R, Denkinger CM, Dheda K, Hoffmann H, Kadyrov A, Lemaitre N, Miller MB, Nikolayevskyy V, Ntinginya EN, Ozkutuk N, Palacios JJ, Popowitch EB, Porcel JM, Teo J, Theron G, Kranzer K.

Int J Tuberc Lung Dis. 2017 May 1;21(5):493-502. doi: 10.5588/ijtld.16.0702. Review.

PMID:
28399963
45.

Can tuberculosis patients in resource-constrained settings afford chest radiography?

Pedrazzoli D, Lalli M, Boccia D, Houben R, Kranzer K.

Eur Respir J. 2017 Mar 22;49(3). pii: 1601877. doi: 10.1183/13993003.01877-2016. Print 2017 Mar. No abstract available.

46.

Relationship Between Time to Initiation of Antiretroviral Therapy and Treatment Outcomes: A Cohort Analysis of ART Eligible Adolescents in Zimbabwe.

Vogt F, Rehman AM, Kranzer K, Nyathi M, Van Griensven J, Dixon M, Ndebele W, Gunguwo H, Colebunders R, Ndlovu M, Apollo T, Ferrand RA.

J Acquir Immune Defic Syndr. 2017 Apr 1;74(4):390-398. doi: 10.1097/QAI.0000000000001274.

47.

Insidious Risk of Severe Mycobacterium chimaera Infection in Cardiac Surgery Patients.

Chand M, Lamagni T, Kranzer K, Hedge J, Moore G, Parks S, Collins S, Del Ojo Elias C, Ahmed N, Brown T, Smith EG, Hoffman P, Kirwan P, Mason B, Smith-Palmer A, Veal P, Lalor MK, Bennett A, Walker J, Yeap A, Isidro Carrion Martin A, Dolan G, Bhatt S, Skingsley A, Charlett A, Pearce D, Russell K, Kendall S, Klein AA, Robins S, Schelenz S, Newsholme W, Thomas S, Collyns T, Davies E, McMenamin J, Doherty L, Peto TE, Crook D, Zambon M, Phin N.

Clin Infect Dis. 2017 Feb 1;64(3):335-342. doi: 10.1093/cid/ciw754. Epub 2016 Dec 7. Erratum in: Clin Infect Dis. 2017 Sep 1;65(5):875.

48.

Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study.

Rawson TM, Abbara A, Kranzer K, Ritchie A, Milburn J, Brown T, Adeboyeku D, Buckley J, Davidson RN, Berry M, Kon OM, John L.

Respir Med. 2016 Nov;120:101-108. doi: 10.1016/j.rmed.2016.10.001. Epub 2016 Oct 6.

49.

Chronic lung disease in HIV-infected children established on antiretroviral therapy.

Rylance J, Mchugh G, Metcalfe J, Mujuru H, Nathoo K, Wilmore S, Rowland-Jones S, Majonga E, Kranzer K, Ferrand RA.

AIDS. 2016 Nov 28;30(18):2795-2803.

50.

What are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysis.

Stagg HR, Harris RJ, Hatherell HA, Obach D, Zhao H, Tsuchiya N, Kranzer K, Nikolayevskyy V, Kim J, Lipman MC, Abubakar I.

Thorax. 2016 Oct;71(10):940-9. doi: 10.1136/thoraxjnl-2015-208262. Epub 2016 Jun 13. Review.

Supplemental Content

Loading ...
Support Center